The present invention provides a pharmaceutical formulation, characterized by comprising aripiprazole monohydrate and super disintegrant and disintegrant mixture. The present invention more particularly relates to a formulation of aripiprazole monohydrate, in which the latter has high solubility, high dissolution rate, and therefore high bioavailability.